2Xideas AG Lowers Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

2Xideas AG lessened its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 38.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 153,897 shares of the company's stock after selling 96,740 shares during the period. 2Xideas AG owned about 0.06% of Ryan Specialty worth $9,874,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in RYAN. Federated Hermes Inc. boosted its stake in shares of Ryan Specialty by 11.4% in the 4th quarter. Federated Hermes Inc. now owns 656,963 shares of the company's stock valued at $42,150,000 after purchasing an additional 67,310 shares during the last quarter. Waterloo Capital L.P. lifted its holdings in Ryan Specialty by 46.9% in the fourth quarter. Waterloo Capital L.P. now owns 9,589 shares of the company's stock valued at $615,000 after buying an additional 3,061 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in Ryan Specialty during the fourth quarter valued at $545,000. Mizuho Bank Ltd. acquired a new stake in Ryan Specialty during the fourth quarter worth approximately $49,000. Finally, Nicolet Advisory Services LLC increased its stake in shares of Ryan Specialty by 9.3% in the 4th quarter. Nicolet Advisory Services LLC now owns 11,301 shares of the company's stock valued at $706,000 after acquiring an additional 963 shares in the last quarter. Institutional investors own 84.82% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. UBS Group boosted their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. TD Cowen began coverage on shares of Ryan Specialty in a research note on Thursday. They issued a "buy" rating and a $89.00 price objective on the stock. Keefe, Bruyette & Woods reduced their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday. Royal Bank of Canada lowered their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. Finally, Wells Fargo & Company cut their price target on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday. One research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $76.08.

Ryan Specialty Stock Performance

Shares of RYAN traded up $0.90 on Friday, reaching $72.85. 270,252 shares of the company's stock traded hands, compared to its average volume of 936,870. The stock's 50 day simple moving average is $69.96 and its two-hundred day simple moving average is $68.82. The stock has a market cap of $19.08 billion, a PE ratio of 104.98, a PEG ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $77.16. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million for the quarter, compared to analysts' expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date was Tuesday, March 4th. This represents a $0.48 annualized dividend and a yield of 0.66%. Ryan Specialty's payout ratio is currently 69.57%.

Insider Buying and Selling at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm's stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00. Following the completion of the transaction, the director now directly owns 35,609 shares of the company's stock, valued at approximately $2,349,837.91. This trade represents a 49.57 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 241,360 shares of company stock worth $16,006,428 over the last three months. 11.10% of the stock is currently owned by insiders.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.